Arrhythmias in the congenital long QT syndrome: How often is torsade de pointes pause dependent?

Heart

Volumn 83, Issue 6, 2000, Pages 661-666

  Viskin, S ^a   Fish, R ^a   Zeltser, D ^a   Belhassen, B ^a   Heller, K ^a   Brosh, D ^a   Laniado, S ^a   Barron, H V ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Congenital long QT syndrome; Long QT; Torsade de pointes; Ventricular tachycardia

Indexed keywords

ADULT; AGE; ARTICLE; DISEASE ASSOCIATION; EXTRASYSTOLE; FEMALE; HEART CYCLE; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MALE; PRIORITY JOURNAL; TORSADE DES POINTES;

EID: 0034082381     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.6.661     Document Type: Article

References (77)

1. Viskin S, Belhassen B. Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease. Classification, differential diagnosis and implications for therapy. Prog Cardiovasc Dis 1998;41:17-34.
2. Viskin S, Alla SR, Barron HV, et al. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardial 1996;28:1262-8.
3. Viskin S, Fish R, Roth A, et al. Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause-prevention pacing algorithm. Heart 1998;79:417-19.
4. Viskin S, Fish R, Brosh D, et al. Prevention of pause-dependent torsade de pointes and malignant ventricular arrhythmias with a pause-preventing pacing algorithm [abstract]. PACE 1998;21(II):II-826.
5. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol 1994;23:259-77.
6. Jackman WM, Friday KJ, Anderson JL, et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988;31: 115-72.
7. Tan HL, Hou CJ, Lauer MR, et al. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 1995;122:701-14.
8. Josephson ME. Recurrent ventricular tachycardia. In: Clinical cardiac electrophysiology. Techniques and interpretations, 2nd ed. Pennsylvania: Lea & Febiger, 1993.
9. Van-Hare GF, Franz MR, Roge C, et al. Persistent functional atrioventricular block in two patients with prolonged QT intervals: elucidation of the mechanism of block. PACE 1990;13:608-18.
10. Bhandari AK, Scheinman MM, Morady F, et al. Efficacy of left cardiac sympathectomy in the treatment of patients with the long QT syndrome. Circulation 1984;70:1018-23.
11. Eldar M, Griffin JC, Abbott JA, et al. Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol 1987;10:600-7.
12. Eldar M, Griffin JC, Van Hare GF, et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol 1992;20:830-7.
13. James TN. Congenital deafness and cardiac arrhythmias. Am J Cardiol 1967;19:627-43.
14. Van-Bruggen HW, Sebus J, Van-Heyst ANP. Convulsive syncope resulting from arrhythmia in a case of congenital deafness with ECG abnormalities. Am Heart J 1969;78:81-6.
15. Garza LA, Vick RL, Nora JJ, et al. Heritable Q-T prolongation without deafness. Circulation 1970;41:39-48.
16. Jervell A. Surdocardiac and related syndromes in children. Adv Intern Med 1971;17:425-38.
17. Ratshin RA, Hunt D, Russell RO Jr, et al. QT-interval prolongation, paroxysmal ventricular arrhythmias, and convulsive syncope. Ann Intern Med 1971;75:919-24.
18. Wellens HJ, Vermeulen A, Durrer D. Ventricular fibrillation occurring on arousal from sleep by auditory stimuli. Circulation 1972;46:661-5.
19. Mathews EC, Blount AW, Townsend JI. Q-T prolongation and ventricular arrhythmias, with and without deafness, in the same family. Am J Cardiol 1972;29:702-11.
20. Pernot C, Henry M, Aigle J. Syndrome cardio-auditif de Jervell et torsades de pointes. Arch Mal Coeur 1972;65:261-74.
21. Johansson BW, Jorming B. Hereditary prolongation of QT interval. Br Heart J 1972;34:744-51.
22. Crawford MH, Karliner JS, O'Rourke RA, et al. Prolonged Q-T interval syndrome. Successful treatment with combined ventricular pacing and propranolol. Chest 1975;68: 369-71.
23. Reynolds E, Vander-Ark CR. Quinidine syncope and the delayed repolarization syndromes. Modern Concepts in Cardiovascular Disease 1976;45:117-22.
24. Roy PR, Emanuel R, Ismail SA, et al. Hereditary prolongation of the Q-T interval. Genetic observations and management in three families with twelve affected members. Am J Cardiol 1976;37:237-43.
25. James TN, Froggatt P, Atkinson WJ, et al. De Subitaneis Mortibus. Observations on the pathophysiology of the long QT syndromes with special reference to the neuropathology of the heart. Circulation 1978;57:1221-32.
26. Curtiss EI, Heibel RH, Shaver JA. Autonomic maneuvers in hereditary Q-T interval prolongation (Romano-Ward syndrome). Am Heart J 1978;95:420-8.
27. DiSegni E, David D, Katzenstein M, et al. Permanent over-drive pacing for the suppression of recurrent ventricular tachycardia in a newborn with long QT syndrome. J Electrocardiol 1980;13:189-92.
28. Mitsutake A, Takeshita A, et al. Usefulness of the valsalva maneuver in management of the long QT syndrome. Circulation 1981;63:1029-35.
29. Hartzler GO, Osborn MJ. Invasive electrophysiological study in the Jervell and Lange-Nielsen syndrome. Br Heart J 1981;45:225-9.
30. Fontaine G, Frank R, Grosgogeat Y. Torsades de pointes: definition and management. Modern Concepts in Cardiovascular Disease 1982;51:103-8.
31. Medina-Ravell V, Castellanos A, Portillo-Acosta B, et al. Management of tachyarrhythmias with dual-chamber pacemakers. Pacing Clin Electrophysiol 1983;6:333-45.
32. Coumel P, Leclercq JF, Lucet V. Possible mechanisms of the arrhythmias in the long QT syndrome. Eur Heart J 1985;6(suppl D):115-29.
33. Wilmer CI, Stein B, Morris DC. Atrioventricular pacemaker placement in Romano-Ward syndrome and recurrent torsades de pointes. Am J Cardiol 1987;59:171-2.
34. Saoudi N, Bozio A, Kirkorian G, et al. Prolonged QT, atrioventricular block, and sudden death in the newborn: an electrophysiologic evaluation. Eur Heart J 1991;12:838-41.
35. Eggeling T, Hoener M, Osterhues HH, et al. Significance of noninvasive diagnostic techniques in patients with long QT syndrome. Am J Cardiol 1992;70:1421-6.
36. Malfatto G, Rosen MR, Foresti A, et al. Idiopathic long QT syndrome exacerbated by beta-adrenergic blockade and responsive to left cardiac sympathetic denervation: implications regarding electrophysiologic substrate and adrenergic modulation. J Cardiovasc Electrophysiol 1992;3:295-305.
37. Zhou JT, Zheng LR, LJU WY, et al. Early afterdepolarization in the familial long QTU syndrome. J Cardiovasc Electrophysiol 1992;3:431-6.
38. Habbab MA, El-Sherif N. TU alternans, long QTU and torsade de pointes: clinical and experimental observations. PACE 1992;15:916-31.
39. Perticone F, Canepa S, Ceravolo R, et al. A case of torsade de pointes occurring in a newborn with persistent 2:1 atrioventricular block. Cardiology 1993;83:134-40.
40. Leenhardt A, Thomas O, Coumel P. Aspects cliniques et electrocardiographiques des torsades de pointes. In: Chauvin M, ed. La mort subite d'origine rythmique. Donnees actuelles. Paris: Editions Frison-Roche, 1994:79-91.
41. Shimizu W, Ohe T, Kurita T, et al. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol 1995;26:1299-309.
42. Nakajima T, Misu K, Iwasawa K, et al. Auditory stimuli as a major cause of syncope in a patient with idiopathic long QT syndrome. Jpn Circ J 1995;59:241-6.
43. Wong CW, Wang CH, Wen MS, et al. Effective therapy with transthoracic video-assisted endoscopic coagulation of the left stellate ganglion and upper sympathetic trunk in congenital long QT syndrome. Am Heart J 1996;132:1060-3.
44. Gronefeld G, Holtgen R, Hohnloser SH. Implantable cardioverter defibrillator therapy in a patient with the idiopathic long QT syndrome. PACE 1996;19:1260-3.
45. Roden D, Lazzara R, Rosen M, et al. Multiple mechanisms in the long QT syndrome. Current knowledge, gaps, and future directions. Circulation 1996;94:1996-2012.
46. Benhorin J, Medina A. Congenital long QT syndrome. N Engl J Med 1997;336:1568.
47. Tanel RE, Triedman JK, Walsh EP, et al. High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome. J Cardiovasc Electrophysiol 1997;8:812-17.
48. Moss AJ. The long QT interval syndrome. Am J Cardiol 1997;79(6A):17-19.
49. Ackerman MJ, Porter CJ. Identification of a family with inherited long QT syndrome after pediatric near-drowning. Pediatrics 1998;101:306-8.
50. Shimono M, Fujiki A, Inoue H. Relation between autonomic nerve activity and QT interval in patients with congenital long QT syndrome: analysis using 24-hour Holter ECG monitoring. Annals of Noninvasive Electrocardiology 1998;3:12-19.
51. Zipes DP. Specific arrhythmias: diagnosis and treatment, 5th ed. Philadelphia: WB Sunders Co, 1997.
52. Pedersen U, Zipes D, Foster P, et al. Ventricular tachycardia and ventricular fibrillation in a young population. Circulation 1979;60:988-97.
53. Bashour T, Rios JC, Gorman PA. U wave alternans and increased ventricular irritability. Chest 1973;64:377-9.
54. Flugelman MY, Pollack S, Hammerman H, et al. Congenital prolongation of QT interval: a family study of three generations. Cardiology 1982;69:170-4.
55. Vlay SC, Mallis GI, Brown EJ, et al. Documented sudden cardiac death in prolonged QT syndrome. Arch Intern Med 1984;144:833-5.
56. Mache CJ, Beitzke A, Haidvogl M, et al. Perinatal manifestations of the idiopathic long QT syndrome. Pediatr Cardiol 1996;17:118-21.
57. Kawade M, Ohe T, Kamiya T. Provocative testing and drug response in a patient with the long QT syndrome. Br Heart J 1995;74:67-70.
58. Garcia-Rubira JC, GArcia-Aranda VL, Cruz-Fernandez JM. Magnesium sulfate for torsade de pointes in a patient with congenital long QT syndrome. Int J Cardiol 1990;27: 282-3.
59. Hsieh MH, Chen SA, Chiang CE, et al. Drug-induced torsade de pointes in one patient with congenital long QT syndrome. Int J Cardiol 1996;54:85-8.
60. Klein HO, Levi A, Kaplinsky E, et al. Congenital long QT syndrome: deleterious effect of long-term high-rate ventricular pacing and definitive treatment by cardiac transplantation. Am Heart J 1996;132:1079-81.
61. Chiladakis J, Karapanos G, Manolis SA. Idiopathic long QT syndrome with late onset of bradycardia-dependent and short-coupled variant of torsade de pointes. Int J Cardiol 1998;64:93-5.
62. 1). J Am Coll Cardiol 1999;33:327-32.
63. Tan HL, Alings M, Van-Olden RW, et al. Long-term (subacute) potassium treatment in congenital HERG-related long QT syndrome (LQTS2). J Cardiovasc Electrophvsiol 1999;10:229-33.
64. El-Sherif N, Turitto G. The long QT syndrome and torsade de pointes. PACE 1999;22(I):91-110.
65. Locati EH, Maison-Blanche P, Dejode P, et al. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings. J Am Coll Cardiol 1995;25:1564-75.
66. El-Sherif N, Caref EB, Chinushi M, et al. Mechanism of arrhythmogenicity of the short-long cardiac sequence that precedes ventricular tachyarrhytmias in the long QT syndrome. J Am Coll Cardiol 1999;33:1415-23.
67. El-Sherif N, Bekheit SS, Henkin R. Quinidine-induced long QTU interval and lorsade de pointes: role of bradycardia-dependent early afterdepolarizations. J Am Coll Cardiol 1989;14:252-7.
68. Viskin S, Lesh MD, Eldar M, et al. Mode of onset of malignant ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 1997;8:1115-20.
69. Kawasaki R, Machado C, Reinoehl J, et al. Increased propensity of women to develop torsade de pointes during complete heart block. J Cardiovasc Electrophysiol 1995;6: 1032-8.
70. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsade de pointes associated with cardiovascular drugs. JAMA 1993;270:2590-7.
71. Garson A, Dick M, Fournier A, et al. The long QT syndrome in children. An international study of 287 patients. Circulation 1993;87:1866-72.
72. El-Sherif N, Zeiler RH, Craelius VT, et al. QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia dependent early afterdepolarizations. Circ Res 1988;63:286-305.
73. Splawski I, Timothy K, Vincent GM, et al. Molecular basis of the long QT syndrome associated with deafness. N Engl J Med 1997;336:1562-7.
74. Schwartz P, Priori S. The long Q-T syndrome. Annals of Noninvasive Electrocardiology 1998;3:63-7.
75. Moss AJ, Liu JE, Gottlieb S, et al. Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation 1991;84:1524-9.
76. Dorostkar PC, Eldar M, Belhassen B, et al. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Circulation 1999;100: 2431-6.
77. Schwartz PJ, Moss AJ, Vincent GM, et al. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993; 88:782-4.